Enochian Biosciences Inc ENOB

NAS: ENOB | ISIN: US29350E1047   6/10/2023
4,600 USD (+6,98%)
(+6,98%)   6/10/2023

30 april 2024 · Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics · Persbericht

24 april 2024 · RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership · Persbericht

18 april 2024 · Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care · Persbericht

15 februari 2024 · Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace · Persbericht

14 februari 2024 · Statement of Renovaro Inc · Persbericht

13 februari 2024 · Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace · Persbericht

13 februari 2024 · AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine · Persbericht

25 januari 2024 · Renovaro Biosciences Announces Results of Special Meeting of Shareholders · Persbericht

16 januari 2024 · Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD · Persbericht

11 oktober 2023 · Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors · Persbericht

10 oktober 2023 · Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors · Persbericht

2 oktober 2023 · Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD · Persbericht

2 oktober 2023 · AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine · Persbericht

29 september 2023 · Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine · Persbericht

30 augustus 2023 · Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort · Persbericht

21 augustus 2023 · Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer · Persbericht

9 augustus 2023 · AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer · Persbericht

23 juni 2023 · Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting · Persbericht

8 juni 2023 · Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review · Persbericht

3 april 2023 · Enochian BioSciences’ CEO Letter to Shareholders · Persbericht

Mijn selecties